Researchers at the Rudolf Virchow Center of the University of Würzburg have unveiled the molecular effectiveness of artemisinins. These new findings have the potential to advance the development of medicines for diseases such as Alzheimer's, schizophrenia and epilepsy. The study was published in the journal Neuron.
Artemisinin is derived from the leaves and flowers of the annual mugwort (Artemisia annua) and has been used in traditional Chinese medicine for centuries. The effectiveness was investigated by the Chinese researcher Tu Youyou and rewarded with the Nobel Prize.
Schematic representation of the formation of gephyrin-artemisinin complex.
Image: Dr. Vikram Kasaragod, Rudolf Virchow Center
Artemisinin and its semi-synthetic derivatives - collectively known as artemisinins - are used to treat the tropical infectious disease malaria. In addition, these molecules also influence multiple cellular processes in humans.
For example, artemisinins are able to activate the immune system against several types of cancer or to regulate the differentiation of pancreatic T-alpha cells, which could potentially be useful in the therapy of diabetes.
Molecular Mechanisms so far unknown
"Although this clinically-approved drug class is well established and has been used in some extent for centuries, it was unclear which molecular mechanisms underlie the corresponding cellular activities, such as target protein rfhumecognition and modulation," explains Dr. Vikram Kasaragod.
The postdoctoral fellow in the research group of Prof. Hermann Schindelin at the Rudolf Virchow Center is the first author of this article in the renowned journal "Neuron" and ensures with this research work a significant gain in knowledge (see also the related Preview by Ryan Hibbs in the same Issue of "Neuron").
Comprehensive model for the regulation of inhibitory neurotransmission developed
The structural biologist was the first to solve the crystal structures of two different artemisinin derivatives - artesunate and artemether - in a complex with gephyrin. By binding to inhibitory glycine and GABAA receptors, gephyrin acts as a central scaffold protein of inhibitory postsynapses in the mammalian central nervous system. Gephyrin has only recently been identified as an artemisinin target protein.
The results clearly demonstrate how artemisinins target the universal receptor binding pocket in gephyrin and compete with the inhibitory neurotransmitter receptors for an overlapping binding site (see picture). These new findings could thus also serve as an effective tool to understand the physiology of the human brain.
According to Kasaragod, the crystal structures form, together with biochemical, electrophysiological and in vivo data, a comprehensive model of the regulation of inhibitory neurotransmission by artemisinine. According to him, this model clearly describes the interactions between proteins and drugs.
Important step for the development of drugs
"Our data not only provide a solid foundation for understanding how artemisinins are recognized by a target molecule, but will also help researchers to develop and optimize these agents into highly specific modulators of gephyrin. These modulators may play an important role in the treatment of neurological diseases such as Alzheimer's disease, schizophrenia and epilepsy," says Schindelin, the lead investigator.
The data published in Neuron are the result of an interdisciplinary collaboration with other groups at the University of Würzburg, the University Medical Center in Hamburg and the University of Copenhagen.
Dr. Vikram Kasaragod postdoctoral fellow in the research group of Prof. Hermann Schindelin at the Rudolf Virchow Center of the University of Würzburg.
Prof. Dr. Hermann Schindelin is Professor of Structural Biology and Biochemistry. Since 2006 he is head of a research group at the Rudolf Virchow Center for Experimental Biomedicine of the University of Würzburg.
Dr. Vikram Kasaragod (Schindelin Group, Rudolf Virchow Center) email@example.com
Prof. Dr. Hermann Schindelin (Rudolf Virchow Center)
Tel. 0931 31 80382, firstname.lastname@example.org
Dr. Daniela Diefenbacher (Press Office, Rudolf Virchow Center)
Tel. 0931 3188631, email@example.com
Vikram Babu Kasaragod, Torben Johann Hausrat, Natascha Schaefer, Maximilian Kuhn, Nikolaj Riis Christensen, Ingrid Tessmer, Hans Michael Maric, Kenneth Lindegaard Madsen, Christoph Sotriffer, Carmen Villmann, Matthias Kneussel and Hermann Schindelin: Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins. Neuron (2019) https://doi.org/10.1016/j.neurin.2019.01.001
Dr. Daniela Diefenbacher | idw - Informationsdienst Wissenschaft
'Flamenco dancing' molecule could lead to better-protecting sunscreen
18.10.2019 | University of Warwick
Synthetic cells make long-distance calls
17.10.2019 | Rice University
A very special kind of light is emitted by tungsten diselenide layers. The reason for this has been unclear. Now an explanation has been found at TU Wien (Vienna)
It is an exotic phenomenon that nobody was able to explain for years: when energy is supplied to a thin layer of the material tungsten diselenide, it begins to...
Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have explored the initial consequences of the interaction of light with molecules on the surface of nanoscopic aerosols.
The nanocosmos is constantly in motion. All natural processes are ultimately determined by the interplay between radiation and matter. Light strikes particles...
Particles that are mere nanometers in size are at the forefront of scientific research today. They come in many different shapes: rods, spheres, cubes, vesicles, S-shaped worms and even donut-like rings. What makes them worthy of scientific study is that, being so tiny, they exhibit quantum mechanical properties not possible with larger objects.
Researchers at the Center for Nanoscale Materials (CNM), a U.S. Department of Energy (DOE) Office of Science User Facility located at DOE's Argonne National...
A new research project at the TH Mittelhessen focusses on the development of a novel light weight design concept for leisure boats and yachts. Professor Stephan Marzi from the THM Institute of Mechanics and Materials collaborates with Krake Catamarane, which is a shipyard located in Apolda, Thuringia.
The project is set up in an international cooperation with Professor Anders Biel from Karlstad University in Sweden and the Swedish company Lamera from...
Superconductivity has fascinated scientists for many years since it offers the potential to revolutionize current technologies. Materials only become superconductors - meaning that electrons can travel in them with no resistance - at very low temperatures. These days, this unique zero resistance superconductivity is commonly found in a number of technologies, such as magnetic resonance imaging (MRI).
Future technologies, however, will harness the total synchrony of electronic behavior in superconductors - a property called the phase. There is currently a...
02.10.2019 | Event News
02.10.2019 | Event News
19.09.2019 | Event News
18.10.2019 | Power and Electrical Engineering
18.10.2019 | Medical Engineering
18.10.2019 | Physics and Astronomy